Synergistic pharmaceutical compositions

Details Synergistic pharmaceutical compositions Synergistic pharmaceutical compositions

1995-06-06

1998-01-13

Criares, Theodore J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

514174, A61K 3156, A61K 3158

Patent

active

057079811

ABSTRACT:
A pharmaceutical composition comprises a synergistic combination of about 0.01-0.15% by wt. triamcinolone acetonide and about 0.04-0.3% by wt. halcinonide as active ingredients, in combination with a pharmaceutically acceptable carrier.

REFERENCES:
patent: 2990401 (1961-06-01), Bernstein et al.
patent: 3035050 (1962-05-01), Hydorn
patent: 3892857 (1975-07-01), Difazio et al.
patent: 3899581 (1975-08-01), Agusti
patent: 3934013 (1976-01-01), Poulsen
patent: 4107161 (1978-08-01), Agusti
patent: 4233295 (1980-11-01), Hill et al.
Cutis (United States), Aug. 1984, vol. 34 No. 2 pp. 190-194, Bicker DR "A comparative study of amcinonide and halcinonide in the treatment of eczematous dermatitis".
Cutis, vol. 42, No. 1, 1990, pp. 84-88 The Actiderm Multi-Center Study Group.
The British Journal of Clinical Practice, vol. 20, No. 10, Oct. 1966, David Haler, "An Assessment of Combined Corticosteriods," pp. 511-514.

Affiliated with

Also associated with

Rating

Synergistic pharmaceutical compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Synergistic pharmaceutical compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synergistic pharmaceutical compositions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-326347